MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $23,000 | -90.0% | 18,865 | -74.6% | 0.00% | – |
| Q1 2017 | $229,000 | +397.8% | 74,358 | +562.7% | 0.00% | – |
| Q4 2016 | $46,000 | -70.5% | 11,220 | -54.4% | 0.00% | – |
| Q3 2016 | $156,000 | -55.4% | 24,600 | -40.2% | 0.00% | -100.0% |
| Q3 2015 | $350,000 | -54.7% | 41,166 | -39.8% | 0.00% | 0.0% |
| Q4 2014 | $772,000 | -48.2% | 68,340 | -59.7% | 0.00% | -50.0% |
| Q3 2014 | $1,490,000 | +1218.6% | 169,710 | +704.0% | 0.00% | – |
| Q4 2013 | $113,000 | +29.9% | 21,107 | -7.9% | 0.00% | – |
| Q3 2013 | $87,000 | +8.8% | 22,907 | +93.3% | 0.00% | – |
| Q2 2013 | $80,000 | – | 11,849 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,100,140 | $25,968,000 | 6.81% |
| Portolan Capital Management | 664,298 | $8,214,000 | 1.15% |
| GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,122,000 | 1.10% |
| Opus Point Partners Management, LLC | 72,009 | $890,000 | 0.70% |
| Eagle Ridge Investment Management | 122,500 | $1,515,000 | 0.68% |
| EAM Investors, LLC | 350,410 | $4,333,000 | 0.51% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,881,667 | $60,362,000 | 0.37% |
| Cannell & Co. | 1,051,178 | $12,998,000 | 0.37% |
| Birchview Capital, LP | 42,300 | $523,000 | 0.28% |
| Tekla Capital Management LLC | 567,787 | $7,021,000 | 0.25% |